NASDAQ:MDSO - Medidata Solutions Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$92.22
+0.30 (1.20%)
Get New Medidata Solutions Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDSO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDSO

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Medidata Solutions in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $92.22.

This chart shows the closing price for MDSO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Medidata Solutions. This rating has held steady since May 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 8 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/13/2019Wells Fargo & CompanyReiterated RatingHoldLow
6/13/2019SunTrust BanksBoost Price TargetHold$85.00 ➝ $92.25Low
6/12/2019Piper Jaffray CompaniesDowngradeOverweight ➝ NeutralLow
6/12/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ NeutralMedium
6/12/2019William BlairDowngradeOutperform ➝ Market PerformHigh
6/12/2019GuggenheimDowngradeBuy ➝ Neutral$92.25High
5/1/2019Dougherty & CoDowngradeBuy ➝ NeutralMedium
4/30/2019Piper Jaffray CompaniesBoost Price TargetOverweight$83.00 ➝ $96.00Low
4/24/2019SunTrust BanksDowngradeBuy ➝ Hold$79.00Medium
4/23/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$90.00High
4/17/2019GuggenheimInitiated CoverageBuy ➝ Buy$92.00High
4/15/2019William BlairInitiated CoverageOutperform ➝ Outperform$74.93High
1/4/2019Piper Jaffray CompaniesLower Price TargetOverweight$83.00High
1/2/2019SVB LeerinkInitiated CoverageMkt Perform ➝ Market Perform$70.00Medium
12/13/2018JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightLow
10/19/2018JPMorgan Chase & Co.Lower Price TargetNeutral$74.00Low
10/19/2018Royal Bank of CanadaSet Price TargetBuy$86.00Low
10/18/2018Piper Jaffray CompaniesLower Price Target$96.00 ➝ $93.00Low
9/25/2018Royal Bank of CanadaLower Price TargetOutperform$91.00Low
7/25/2018Morgan StanleySet Price TargetEqual Weight ➝ Hold$79.00 ➝ $84.00Medium
7/25/2018Needham & Company LLCDowngradeBuy ➝ HoldMedium
7/24/2018Royal Bank of CanadaSet Price TargetBuy$98.00Medium
7/24/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$87.00High
7/17/2018Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$100.00High
6/14/2018First AnalysisInitiated CoverageEqual ➝ Equal Weight$86.00Medium
6/13/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$85.00 ➝ $90.00Medium
6/13/2018Needham & Company LLCBoost Price TargetBuy$80.00 ➝ $90.00Low
6/1/2018Morgan StanleyReiterated RatingEqual WeightLow
5/31/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$78.00 ➝ $85.00Low
5/23/2018Piper Jaffray CompaniesBoost Price TargetOverweight$98.00Low
5/21/2018Morgan StanleyDowngradeOverweight ➝ Hold$79.00High
5/10/2018Dougherty & CoReiterated RatingBuy ➝ Buy$79.00 ➝ $89.00Medium
4/20/2018Needham & Company LLCBoost Price TargetBuy$80.00Medium
2/9/2018Needham & Company LLCLower Price TargetBuy$75.00Low
2/9/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$86.00 ➝ $79.00Low
2/8/2018Royal Bank of CanadaSet Price TargetHold$82.00Medium
12/8/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$78.00Low
12/1/2017Wells Fargo & CompanyUpgradeMarket Perform ➝ Outperform$80.00Low
11/13/2017Dougherty & CoUpgradeNeutral ➝ Buy$75.00N/A
11/2/2017Dougherty & CoInitiated CoverageNeutral ➝ NeutralN/A
10/27/2017Royal Bank of CanadaReiterated RatingHold$80.00N/A
10/27/2017SunTrust BanksReiterated RatingBuy$92.00N/A
10/27/2017Wells Fargo & CompanyLower Price TargetMarket Perform$83.00 ➝ $80.00N/A
9/19/2017Royal Bank of CanadaInitiated CoverageSector Perform ➝ Sector Perform$82.00Low
9/17/2017KeyCorpReiterated RatingBuy$86.00Low
8/22/2017Jefferies Financial GroupReiterated RatingHold$78.00Medium
7/24/2017CitigroupReiterated RatingBuy$94.00 ➝ $95.00Low
7/21/2017Needham & Company LLCReiterated RatingBuy$75.00 ➝ $90.00Low
7/20/2017Morgan StanleyBoost Price TargetOverweight$74.00 ➝ $86.00Low
7/18/2017JPMorgan Chase & Co.Boost Price TargetOverweight$87.00High
7/10/2017CitigroupReiterated RatingBuy$77.00 ➝ $94.00Medium
7/7/2017Piper Jaffray CompaniesBoost Price TargetOverweight$87.00High
6/27/2017SunTrust BanksBoost Price TargetBuy$80.00 ➝ $90.00Low
6/14/2017Morgan StanleySet Price TargetBuy$74.00Low
6/6/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$85.00High
5/11/2017KeyCorpBoost Price TargetOverweight$71.00 ➝ $74.00Low
5/1/2017Jefferies Financial GroupUpgradeUnderperform ➝ Hold$47.00 ➝ $46.00Medium
4/28/2017Morgan StanleyBoost Price TargetOverweight$63.00 ➝ $74.00Low
4/28/2017Jefferies Financial GroupUpgradeUnderperform ➝ Hold$46.00Low
4/27/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$65.00 ➝ $75.00High
4/19/2017Needham & Company LLCReiterated RatingBuy$65.00High
4/11/2017Piper Jaffray CompaniesBoost Price TargetOverweight$60.00 ➝ $72.00Low
2/16/2017Jefferies Financial GroupReiterated RatingUnderperform$46.00 ➝ $47.00N/A
2/10/2017Jefferies Financial GroupBoost Price Target$47.00N/A
2/10/2017Needham & Company LLCBoost Price TargetBuy$60.00 ➝ $65.00N/A
2/10/2017SunTrust BanksUpgradeNeutral ➝ Buy$60.00 ➝ $70.00N/A
12/4/2016Pacific CrestSet Price TargetBuy$65.00N/A
11/22/2016Jefferies Financial GroupBoost Price TargetUnderperform$41.00 ➝ $46.00N/A
10/26/2016Jefferies Financial GroupBoost Price TargetUnderperform$36.00 ➝ $41.00N/A
9/13/2016Deutsche Bank AktiengesellschaftBoost Price TargetBuy$56.00 ➝ $58.00N/A
8/25/2016Morgan StanleyReiterated RatingBuy$61.00N/A
7/24/2016Needham & Company LLCReiterated RatingBuy$55.00 ➝ $60.00N/A
7/21/2016Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformN/A
7/11/2016Needham & Company LLCInitiated CoverageBuy$55.00N/A
7/7/2016KeyCorpReiterated RatingBuyN/A
(Data available from 6/21/2016 forward)
Medidata Solutions logo
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company was founded in 1999 and is headquartered in New York, New York.
Read More

Today's Range

Now: $92.22
Low: $92.21
High: $92.26

50 Day Range

MA: $92.20
Low: $91.79
High: $92.25

52 Week Range

Now: $92.22
Low: $60.10
High: $98.60

Volume

7,301,589 shs

Average Volume

1,239,614 shs

Market Capitalization

$5.76 billion

P/E Ratio

96.06

Dividend Yield

N/A

Beta

1.22

Frequently Asked Questions

What sell-side analysts currently cover shares of Medidata Solutions?

The following equities research analysts have issued reports on Medidata Solutions in the last year:
View the latest analyst ratings for MDSO.

What is the current price target for Medidata Solutions?

0 Wall Street analysts have set twelve-month price targets for Medidata Solutions in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Medidata Solutions in the next year.
View the latest price targets for MDSO.

What is the current consensus analyst rating for Medidata Solutions?

Medidata Solutions currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MDSO.

What other companies compete with Medidata Solutions?

How do I contact Medidata Solutions' investor relations team?

Medidata Solutions' physical mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company's listed phone number is 212-918-1800 and its investor relations email address is [email protected] The official website for Medidata Solutions is www.mdsol.com.